SMAD3 and type 2 diabetes mellitus: Our findings that a small molecule inhibitor of the TβR1 kinase, SB431542, protects T2D human islets from β-cell apoptosis supports the notion that controlled blockade of TGF-β/Smad3 signals may indeed be beneficial.